Albumin-to-Globulin Ratio Combined with Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor in Multiple Myeloma with Renal Impairment

References

• Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol. 2016;43(6):676–681. doi:10.1053/j.seminoncol.2016.11.004
   PubMed Web of Science ®Google Scholar
• Augustson BM, Begum G, Dunn JA, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23(36):9219–9226. doi:10.1200/JCO.2005.03.2086
   PubMed Web of Science ®Google Scholar
• Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36(3):842–854. doi:10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book. 2016;35(36):e418–423. doi:10.1200/EDBK_159009
   PubMedGoogle Scholar
• Cossu G, Terrier LM, Benboubker L, et al. Spinal metastases in multiple myeloma: a high-risk subgroup for ISS III patients. Surg Oncol. 2018;27(2):321–326. doi:10.1016/j.suronc.2018.05.005
   PubMed Web of Science ®Google Scholar
• Bataille R, Annweiler C, Beauchet O. Multiple myeloma international staging system: “staging” or simply “aging” system? Clin Lymphoma Myeloma Leuk. 2013;13(6):635–637. doi:10.1016/j.clml.2013.07.003
   PubMed Web of Science ®Google Scholar
• Hu H, Yao X, Xie X, et al. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. World J Urol. 2017;35(2):261–270. doi:10.1007/s00345-016-1864-9
   PubMed Web of Science ®Google Scholar
• Mirili C, Guney IB, Paydas S, et al. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Int J Clin Oncol. 2019;24(2):168–178. doi:10.1007/s10147-018-1338-8
   PubMed Web of Science ®Google Scholar
• Miyamoto R, Inagawa S, Sano N,et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol. 2018;44(5):607–612. doi:10.1016/j.ejso.2018.02.003
   PubMed Web of Science ®Google Scholar
• Balta S, Celik T, Mikhailidis DP, et al. The Relation Between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clin Appl Thromb Hemost. 2016;22(5):405–411. doi:10.1177/1076029615569568
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 2016;36:94–99. doi:10.1016/j.intimp.2016.04.006
   PubMed Web of Science ®Google Scholar
• Wu PP, Hsieh YP, Kor CT, Chiu PF. Association between albumin-globulin ratio and mortality in patients with chronic kidney disease. J Clin Med. 2019;8(11):1991. doi:10.3390/jcm8111991
   PubMed Web of Science ®Google Scholar
• Beamer N, Coull BM, Sexton G, de Garmo P, Knox R, Seaman G. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke. 1993;24(8):1133–1139. doi:10.1161/01.STR.24.8.1133
   PubMed Web of Science ®Google Scholar
• Niedziela JT, Hudzik B, Szygula-Jurkiewicz B, et al. Albumin-to-globulin ratio as an independent predictor of mortality in chronic heart failure. Biomarker Med. 2018;12(7):749–757. doi:10.2217/bmm-2017-0378
   PubMed Web of Science ®Google Scholar
• Yue W, Liu B, Gao L, et al. The pretreatment albumin to globulin ratio as a significant predictor in patients with diffuse large B cell lymphoma. Clin Chim Acta. 2018;485:316–322. doi:10.1016/j.cca.2018.07.015
   PubMed Web of Science ®Google Scholar
• Stefaniuk P, Szymczyk A, Podhorecka M. The neutrophil to lymphocyte and lymphocyte to monocyte ratios as new prognostic factors in hematological malignancies - A narrative review. Cancer Manag Res. 2020;12:2961–2977. doi:10.2147/CMAR.S245928
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–254. doi:10.7326/0003-4819-145-4-200608150-00004
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Terpos E, Chanan-Khan A, et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the international myeloma working group. J Clin Oncol. 2010;28(33):4976–4984. doi:10.1200/JCO.2010.30.8791
   PubMed Web of Science ®Google Scholar
• Shi L, Qin X, Wang H, et al. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Oncotarget. 2017;8(12):18792–18801. doi:10.18632/oncotarget.13320
   PubMedGoogle Scholar
• Zhao WM, Tao SM, Liu GL. Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2020;42(1):1059–1066. doi:10.1080/0886022X.2020.1832521
   PubMed Web of Science ®Google Scholar
• Brito AB, Lourenco GJ, Oliveira GB, De Souza CA, Vassallo J, Lima CS. Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma. Ann Hematol. 2014;93(8):1363–1369. doi:10.1007/s00277-014-2062-8
   PubMed Web of Science ®Google Scholar
• Podar K, Anderson KC. Inhibition of VEGF signaling pathways in multiple myeloma and other malignancies. Cell Cycle. 2007;6(5):538–542. doi:10.4161/cc.6.5.3922
   PubMed Web of Science ®Google Scholar
• Gorgun GT, Whitehill G, Anderson JL, et al. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood. 2013;121(15):2975–2987. doi:10.1182/blood-2012-08-448548
   PubMed Web of Science ®Google Scholar
• Azab B, Bibawy J, Harris K, et al. Value of albumin-globulin ratio as a predictor of all-cause mortality after non-ST elevation myocardial infarction. Angiology. 2013;64(2):137–145. doi:10.1177/0003319712436577
   PubMed Web of Science ®Google Scholar
• Bozkaya Y, Erdem GU, Demirci NS, et al. Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients. Curr Med Res Opin. 2019;35(2):275–282. doi:10.1080/03007995.2018.1479683
   PubMed Web of Science ®Google Scholar
• Koparal MY, Polat F, Cetin S, Bulut EC, Sozen TS. Prognostic role of preoperative albumin to globulin ratio in predicting survival of clear cell renal cell carcinoma. Int Braz J Urol. 2018;44(5):933–946. doi:10.1590/s1677-5538.ibju.2018.0012
   PubMed Web of Science ®Google Scholar
• Morgan WL, Engel GL, Luria MN. The general clerkship: a course designed to teach the clinical approach to the patient. J Med Educ. 1972;47(7):556–563.
   PubMedGoogle Scholar
• Seaton K. Albumin concentration controls cancer. J Natl Med Assoc. 2001;93(12):490–493.
   PubMed Web of Science ®Google Scholar
• Chen JH, Hsu SN, Huang TC, et al. Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma. PLoS One. 2015;10(6):e0128905. doi:10.1371/journal.pone.0128905
   PubMed Web of Science ®Google Scholar
• Das UN. Albumin to globulin ratio and/or plasma albumin in predicting long-term mortality. Am J Surg. 2014;208(1):157–158. doi:10.1016/j.amjsurg.2013.08.055
   PubMed Web of Science ®Google Scholar
• Shiroyama T, Suzuki H, Tamiya M, et al. Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer. Cancer Med. 2017;7(1):13–20. doi:10.1002/cam4.1234
   PubMed Web of Science ®Google Scholar
• He X, Guo S, Chen D, et al. Preoperative albumin to globulin ratio (AGR) as prognostic factor in renal cell carcinoma. J Cancer. 2017;8(2):258–265. doi:10.7150/jca.16525
   PubMed Web of Science ®Google Scholar
• Tsai CC, Hsieh YP, Tsai SM, et al. Superiority of albumin–globulin ratio over albumin to predict mortality in patients undergoing peritoneal dialysis. Sci Rep. 2020;10(1):19764. doi:10.1038/s41598-020-73629-5
   PubMed Web of Science ®Google Scholar
• Xuan Q, Yang Y, Ji H, et al. Combination of the preoperative albumin to globulin ratio and neutrophil to lymphocyte ratio as a novel prognostic factor in patients with triple negative breast cancer. Cancer Manag Res. 2019;11:5125–5131. doi:10.2147/CMAR.S195324
   PubMed Web of Science ®Google Scholar
• Wierda WG, O’Brien S, Wang X, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood. 2007;109(11):4679–4685. doi:10.1182/blood-2005-12-051458
   PubMed Web of Science ®Google Scholar
• Xia WK, Liu ZL, Shen D, Lin QF, Su J, Mao WD. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma. World J Surg Oncol. 2016;14(1):127. doi:10.1186/s12957-016-0889-2
   PubMedGoogle Scholar